Trial intelligence / Profile preview

Intrathecal morphine for laparoscopic surgery analgesia

NCT00772187Phase 4

Key facts

Status
Completed
Start
Oct 2007
Primary completion
Sep 2009
Countries
1
Sponsor
Rambam Health Care Campus
Modality
Small Molecules
Conditions
postoperative pain
01

Overview

Phase 4, randomised, open-label trial of morphine in postoperative pain (2 arms), sponsored by Rambam Health Care Campus. Primary endpoint: Good analgesic method with minimal side effect. Started Oct 2007; status: completed.

02

Design

2 arms
Study design
RandomizedOpen-label
  • General anesthesia + I.V pca

    General anesthesia with fentanyl and IV PCA.

  • General anesthesia + spinal analgesia + I.V pca

    General anesthesia with fentanyl, intrathecal morphine, and IV PCA.

03

Who it enrols

Adult patients (ASA < 4) undergoing morning laparoscopic surgery.

04

Endpoints

Primary

  • Good analgesic method with minimal side effect

Beyond the preview

Go deeper on NCT00772187.

Full results, competitive context and analysis are in the Gosset platform.

Full results & analysis

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00772187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call